SBIR/STTR Research Award

A Microneedle Array System for Transcutaneous Nerve Mapping

Award identifier 836264d05f0c3b1d4eb4aebef3370ee35c3ecca77660d22a68d7ef91629289e5Awarding agency Department of Health and Human Services · National Institutes of Health

Award amount

$556,989

Program and phase

SBIR · Phase I

Award year

2009

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
National Institutes of Health
Recipient company
Axion Biosystems, Inc.
Proposal award date
Not reported
Contract end date
Not reported
UEI
XCMKL76UJL15
Solicitation number
PHS2009-2
Topic code
Not reported

Research abstract

DESCRIPTION (provided by applicant): The proposed study utilizes novel electronics and microfabrication techniques to create a non-invasive, automated platform for targeted monitoring and manipulation of human neural tissue. This research will enable rapid advancements in both basic research and clinical medical devices, with applications to neuropathological diagnostics, advanced therapeutics, and neural prosthetics. Phase I involves three significant developments for non-invasive neurotechnology. Aim 1 will develop high-resolution and low-noise skin surface electrode arrays. Each electrode within the array will contain low-cost micropat- terned needles, which dramatically decrease electrode impedance by painlessly piercing the topmost layer of skin, allowing for high spatial resolution without any sacrifice in signal-to-noise ratios. Aim 2 will develop scalable simultaneous stimulation and re- cording electronics to recover signals traditionally obscured by stimulation artifacts. The recovered data, combined with the ability to simultaneously interact with dozens of skin- surface electrodes, will provide new measures of transcutaneous nerve and muscle activ- ity. Finally, Aim 3 will combine the technological developments of Aims 1 and 2 to dem- onstrate the segmentation and characterization of nerves through the skin. In addition to reducing the complexity, pain, and operator training required to perform traditional nerve conduction studies (NCS), this platform will enable a wide range of basic research studies as well as the creation of novel neuromodulation devices. Phase 2 will focus on increasing the number of channels serviced by the array and electronics, reducing the form factor and processing requirements for the electronics, and providing signal- processing hardware and algorithms for real-time information extraction and neural control. PUBLIC HEALTH RELEVANCE: This research project leverages novel electronic and fabrication technologies to produce a non-invasive automated toolset for the study of nerve, muscle, and brain tissue. Ulti- mately, this development will facilitate medical and scientific discoveries that will enable the diagnosis and therapeutic treatment of neuromuscular diseases.

Technology keywords

Not reported

Other awards by this recipient

Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.

Research funding history

9 SBIR/STTR records share this UEI (2008–2018). Reported award amounts total $10,706,223. Reported amounts are not federal obligations.

Phases: Phase II, Phase I

Agencies: Department of Health and Human Services

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.